(Q47926332)

English

Miltefosine-unresponsive Leishmania donovani has a greater ability than miltefosine-responsive L. donovani to resist reactive oxygen species

scientific article published on 23 August 2013

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/23890327

Miltefosine-unresponsive Leishmania donovani has a greater ability than miltefosine-responsive L. donovani to resist reactive oxygen species (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/23890327

1 reference

ChEBI release 2020-05-28

reactive oxygen species

1 reference

based on heuristic

inferred from title

Leishmania donovani

object named as

Leishmania donovani

1 reference

based on heuristic

inferred from title

3

object named as

Shyam Sundar

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

author name string

Mousumi Das

1

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/23890327

Prakash Saudagar

2

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/23890327

Vikash K Dubey

4

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/23890327

language of work or name

0 references

publication date

23 August 2013

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/23890327

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/23890327

280

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/23890327

19

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/23890327

4807-4815

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/23890327

Oral miltefosine for Indian visceral leishmaniasis

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12449

21 January 2018

Anti-cancer alkyl-lysophospholipids inhibit the phosphatidylinositol 3-kinase-Akt/PKB survival pathway

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12449

21 January 2018

Miltefosine (hexadecylphosphocholine) inhibits cytochrome c oxidase in Leishmania donovani promastigotes

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12449

21 January 2018

Mechanisms of experimental resistance of Leishmania to miltefosine: Implications for clinical use.

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12449

21 January 2018

Inactivation of the miltefosine transporter, LdMT, causes miltefosine resistance that is conferred to the amastigote stage of Leishmania donovani and persists in vivo

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12449

21 January 2018

Characterisation of Leishmania donovani promastigotes resistant to hexadecylphosphocholine (miltefosine).

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12449

21 January 2018

Alteration of fatty acid and sterol metabolism in miltefosine-resistant Leishmania donovani promastigotes and consequences for drug-membrane interactions

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12449

21 January 2018

Role of mitochondrial electron transport chain complexes in capsaicin mediated oxidative stress leading to apoptosis in pancreatic cancer cells

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12449

21 January 2018

Tolerance to drug-induced cell death favours the acquisition of multidrug resistance in Leishmania

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12449

21 January 2018

Reactive oxygen species and nitric oxide in cutaneous leishmaniasis.

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12449

21 January 2018

Evaluation of selected antitumor agents as subversive substrate and potential inhibitor of trypanothione reductase: an alternative approach for chemotherapy of Leishmaniasis

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12449

21 January 2018

Molecular basis of antimony treatment in leishmaniasis

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12449

21 January 2018

An intracellular calcium store is present in Leishmania donovani glycosomes

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12449

21 January 2018

Identifiers

10.1111/FEBS.12449

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/23890327

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/23890327

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47926332&oldid=2175957176"